Holen Sie sich die Stockscreener-App
11.92
13.09%
1.38
Handel nachbörslich:
11.91
-0.010
-0.08%
Schlusskurs vom Vortag:
$10.54
Offen:
$10.71
24-Stunden-Volumen:
867.09K
Relative Volume:
2.11
Marktkapitalisierung:
$333.63M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-17.28
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
+10.47%
1M Leistung:
+4.56%
6M Leistung:
-35.15%
1J Leistung:
+20.28%
1-Tages-Spanne:
$10.46
$11.95
1-Wochen-Bereich:
$10.38
$11.95
52-Wochen-Spanne:
$9.40
$19.22
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.92 | 299.61M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q2 2025 Earnings Call Transcript - Insider Monkey
ClearPoint Neuro outlines global expansion plans and anticipates regulatory milestones while advancing cell and gene therapy initiatives - MSN
Retail investors account for 49% of ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) ownership, while institutions account for 42% - Yahoo Finance
ClearPoint Neuro (CLPT): Navigating Growth Amid Margin Pressures—Is Now the Time to Enter? - AInvest
ClearPoint Neuro Inc (CLPT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
ClearPoint Neuro Achieves Record Revenue in Q2 2025 - TipRanks
ClearPoint Neuro 2025 Q2 Earnings Wider Losses Amid Revenue Growth - AInvest
ClearPoint Neuro's Q2 2025: Key Contradictions in MRI Utilization, GLP Compliance, and Revenue Growth - AInvest
ClearPoint Neuro Outlines Global Expansion Plans and Advances Cell and Gene Therapy Initiatives - AInvest
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates - Nasdaq
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts By Investing.com - Investing.com Nigeria
Earnings call transcript: Clearpoint Neuro’s Q2 2025 earnings miss forecasts - Investing.com
ClearPoint Neuro, Inc. SEC 10-Q Report - TradingView
Clearpoint Neuro earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
ClearPoint Neuro Q2 Loss Widens, Revenue Rises - MarketScreener
ClearPoint Neuro: Balancing Near-Term Earnings Pressure with Long-Term R&D-Driven Growth - AInvest
ClearPoint Neuro Reports Q2 2025 Record Revenue of $9.2mln, 17% YoY Increase - AInvest
ClearPoint Neuro Reports Second Quarter 2025 Results - ACCESS Newswire
How moving averages guide ClearPoint Neuro Inc. tradingPrice Spike Prediction for Active Traders - Newser
Is ClearPoint Neuro Inc. stock reversal real or fakeFree Day Trading Signals With High Precision - Newser
Will ClearPoint Neuro Inc. stock go up soonFree Entry Plan for Oversold Reversal Stocks - Newser
Why ClearPoint Neuro Inc. stock attracts strong analyst attentionQuick Profit Setup with Signal Forecast - Newser
Detecting support and resistance levels for ClearPoint Neuro Inc.Trade Safety Matrix for Conservative Traders - Newser
Is ClearPoint Neuro Inc. stock entering bullish territoryFree Community Entry Consensus Trade Ideas - Newser
How high can ClearPoint Neuro Inc. stock price go in 2025Free Reversal Alert Based on RSI Indicator - Newser
Chart based analysis of ClearPoint Neuro Inc. trendsFree Risk Controlled Short Term Trade Plans - Newser
Live market analysis of ClearPoint Neuro Inc.Smart Trend Analysis With Buy Point Cues - Newser
Is it too late to sell ClearPoint Neuro Inc.Support and Resistance Zone Summary Chart - Newser
Leading vs lagging indicators on ClearPoint Neuro Inc. performancePredictable Income Summary for Long-Term Trades - Newser
Is ClearPoint Neuro Inc. meeting your algorithmic filter criteriaTechnical Setup Guide for Daily Watchlist - Newser
ClearPoint Neuro (CLPT) to Release Earnings on Tuesday - Defense World
ClearPoint Neuro CLPT 2025Q2 Earnings Preview Upside Potential on Innovative Product Launch - AInvest
How ClearPoint Neuro Inc. stock performs during market volatilitySector-Wise Stock Strength Trend Analysis - Newser
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Analyzing net buyer seller activity in ClearPoint Neuro Inc.Daily Market Momentum Summary and Strategy - Newser
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio - ACCESS Newswire
Breakthrough: US Hospitals Complete First-Ever Commercial Gene Therapy Brain Treatments for Rare Disease - Stock Titan
How does ClearPoint Neuro Inc. generate profit in a changing economyHigh-profit capital plays - Jammu Links News
What catalysts could drive ClearPoint Neuro Inc. stock higher in 2025Achieve unparalleled market performance - Jammu Links News
What are analysts’ price targets for ClearPoint Neuro Inc. in the next 12 monthsFree Trend-Following Techniques - Jammu Links News
What are the technical indicators suggesting about ClearPoint Neuro Inc.Accelerated earnings growth - Jammu Links News
Should I hold or sell ClearPoint Neuro Inc. stock in 2025Invest confidently with professional market insights - Jammu Links News
Is ClearPoint Neuro Inc. stock overvalued or undervaluedExplosive wealth accumulation - Jammu Links News
How many analysts rate ClearPoint Neuro Inc. as a “Buy”Exceptional stock performance - Jammu Links News
How strong is ClearPoint Neuro Inc. company’s balance sheetBuild wealth faster with consistent growth stocks - Jammu Links News
ClearPoint Neuro Inc. Tests 50 Day MA After Sharp DeclineGrowth Based Stock Signal Screener Updated - beatles.ru
Is ClearPoint Neuro Inc. a good long term investmentFree Trend-Following Techniques - Jammu Links News
When is ClearPoint Neuro Inc. stock expected to show significant growthInvest smarter with daily market updates - Jammu Links News
What analysts say about ClearPoint Neuro Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is ClearPoint Neuro Inc. a growth stock or a value stockUnlock powerful portfolio optimization tools - Jammu Links News
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):